FIE 📈 Fielmann Aktiengesellschaft - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE0005772206
FIE: Glasses, Frames, Lenses, Sunglasses, Contact Lenses, Hearing Aids, Accessories
Fielmann Group AG provides optical and hearing aid services in Germany, Switzerland, Austria, and internationally. It manufactures and sells visual aids mainly glasses, frames, lenses, sunglasses, contact lenses, accessories, hearing aids systems and its accessories, as well as personal protective equipment. The company offers its products under the fielmann, Optika Clarus, OPTICA & AUDIOLOGIA UNIVERSITARIA, Medical optica audicion, and SVS VISION brand names. It sells its products through digital sales, retail stores, as well as Befitting, an optical e-commerce platform. The company was formerly known as Fielmann Aktiengesellschaft and changed its name to Fielmann Group AG in July 2023. Fielmann Group AG was founded in 1972 and is headquartered in Hamburg, Germany. The company is a subsidiary of Korva SE. Web URL: https://www.fielmann-group.com
Additional Sources for FIE Stock
FIE Stock Overview
| Market Cap in USD | 3,656m |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| GiC Sub-Industry | Health Care Equipment |
| IPO / Inception |
FIE Stock Ratings
| Growth 5y | -51.4% |
| Fundamental | 63.3% |
| Dividend | 15.1% |
| Rel. Strength Industry | -699 |
| Analysts | - |
| Fair Price Momentum | 36.07 EUR |
| Fair Price DCF | 60.37 EUR |
FIE Dividends
| Dividend Yield 12m | 2.44% |
| Yield on Cost 5y | 1.58% |
| Annual Growth 5y | -16.96% |
| Payout Consistency | 93.7% |
FIE Growth Ratios
| Growth Correlation 3m | -74.2% |
| Growth Correlation 12m | -21.8% |
| Growth Correlation 5y | -69.4% |
| CAGR 5y | -8.19% |
| CAGR/Mean DD 5y | -0.30 |
| Sharpe Ratio 12m | -0.72 |
| Alpha | -33.72 |
| Beta | 0.80 |
| Volatility | 25.32% |
| Current Volume | 29.1k |
| Average Volume 20d | 40.3k |
What is the price of FIE stocks?
As of December 21, 2024, the stock is trading at EUR 40.90 with a total of 29,098 shares traded.
Over the past week, the price has changed by +0.37%, over one month by +2.36%, over three months by -11.79% and over the past year by -13.97%.
As of December 21, 2024, the stock is trading at EUR 40.90 with a total of 29,098 shares traded.
Over the past week, the price has changed by +0.37%, over one month by +2.36%, over three months by -11.79% and over the past year by -13.97%.
Is Fielmann Aktiengesellschaft a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Fielmann Aktiengesellschaft (XETRA:FIE) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 63.30 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FIE as of December 2024 is 36.07. This means that FIE is currently overvalued and has a potential downside of -11.81%.
Yes, based on ValueRay Fundamental Analyses, Fielmann Aktiengesellschaft (XETRA:FIE) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 63.30 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FIE as of December 2024 is 36.07. This means that FIE is currently overvalued and has a potential downside of -11.81%.
Is FIE a buy, sell or hold?
Fielmann Aktiengesellschaft has no consensus analysts rating.
Fielmann Aktiengesellschaft has no consensus analysts rating.
What are the forecast for FIE stock price target?
According to ValueRays Forecast Model, FIE Fielmann Aktiengesellschaft will be worth about 39.8 in December 2025. The stock is currently trading at 40.90. This means that the stock has a potential downside of -2.76%.
According to ValueRays Forecast Model, FIE Fielmann Aktiengesellschaft will be worth about 39.8 in December 2025. The stock is currently trading at 40.90. This means that the stock has a potential downside of -2.76%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 56.5 | 38.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 39.8 | -2.8% |